| Literature DB >> 26511494 |
Chip Caine1,2, Snehal Deshmukh3, Vinai Gondi4,5, Minesh Mehta6, Wolfgang Tomé7, Benjamin W Corn8, Andrew Kanner8, Howard Rowley6, Vijayananda Kundapur9, Albert DeNittis10, Jeffrey Noah Greenspoon11, Andre A Konski12, Glenn S Bauman13, Adam Raben14, Wenyin Shi15, Merideth Wendland16, Lisa Kachnic17.
Abstract
Whole brain radiotherapy (WBRT) is associated with memory dysfunction. As part of NRG Oncology RTOG 0933, a phase II study of WBRT for brain metastases that conformally avoided the hippocampal stem cell compartment (HA-WBRT), memory was assessed pre- and post-HA-WBRT using both traditional and computerized memory tests. We examined whether the computerized tests yielded similar findings and might serve as possible alternatives for assessment of memory in multi-institution clinical trials. Adult patients with brain metastases received HA-WBRT to 30 Gy in ten fractions and completed Hopkins Verbal Learning Test-Revised (HVLT-R), CogState International Shopping List Test (ISLT) and One Card Learning Test (OCLT), at baseline, 2 and 4 months. Tests' completion rates were 52-53 % at 2 months and 34-42 % at 4 months. All baseline correlations between HVLT-R and CogState tests were significant (p ≤ 0.003). At baseline, both CogState tests and one component of HVLT-R differentiated those who were alive at 6 months and those who had died (p ≤ 0.01). At 4 months, mean relative decline was 7.0 % for HVLT-R Delayed Recall and 18.0 % for ISLT Delayed Recall. OCLT showed an 8.0 % increase. A reliable change index found no significant changes from baseline to 2 and 4 months for ISLT Delayed Recall (z = -0.40, p = 0.34; z = -0.68, p = 0.25) or OCLT (z = 0.15, p = 0.56; z = 0.41, p = 0.66). Study findings support the possibility that hippocampal avoidance may be associated with preservation of memory test performance, and that these computerized tests also may be useful and valid memory assessments in multi-institution adult brain tumor trials.Entities:
Keywords: HVLT-R; ISLT; NRG Oncology RTOG 0933; Neurocognitive; OCLT
Mesh:
Year: 2015 PMID: 26511494 PMCID: PMC4891977 DOI: 10.1007/s11060-015-1971-2
Source DB: PubMed Journal: J Neurooncol ISSN: 0167-594X Impact factor: 4.130